This is intended for HCPs practising in Great Britain (England, Scotland, Wales) only.
Prescribing Information for SARCLISA®▼ (isatuximab) can be found via the Product Card at the bottom of the page.

Supporting your Patients

Articles and materials to support your patient’s needs

 

SARCLISA® ▼ (isatuximab) patient booklet

Relapsed Refractory Multiple Myeloma Product

SARCLISA
isatuximab

Prescribing Information GB
GB ONLY CONTENT

 

MAT-XU-2202578 (v2.0)
Date of preparation: August 2023

Click here for product and therapy information and related patient case study videos.

Oncology

MAT-XU-2203826 (v1.0)
Date of preparation: September 2023

▼This medicinal product is subject to additional monitoring. This will allow quick identification of new safety information. Healthcare professionals are asked to report any suspected adverse reactions.